Fuso Pharmaceutical Industries,Ltd.

TSE:4538 Stock Report

Market Cap: JP¥20.9b

Fuso Pharmaceutical IndustriesLtd Management

Management criteria checks 2/4

Fuso Pharmaceutical IndustriesLtd's CEO is Mikio Toda, appointed in Feb 1979, has a tenure of 47.67 years. directly owns 2.12% of the company’s shares, worth ¥441.24M. The average tenure of the management team and the board of directors is 3.7 years and 7.6 years respectively.

Key information

Mikio Toda

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure46yrs
CEO ownership2.1%
Management average tenure3.7yrs
Board average tenure7.6yrs

Recent management updates

Recent updates

CEO

Mikio Toda (81 yo)

46yrs

Tenure

Mr. Mikio Toda has been the President and Representative Director of Fuso Pharmaceutical Industries,Ltd. since February 1979 and June 1977 respectively. Mr. Toda Joined Fuso Pharmaceutical Industries Ltd....

Leadership Team

NamePositionTenureCompensationOwnership
Mikio Toda
President & Representative Director46yrsno data2.12%
¥ 441.2m
Haruhiko Furuichi
Executive Officerno datano datano data
Mitsuro Uotani
Executive Officer & Head of Distribution Management Dept. and Sales Divisionno datano datano data
Syoukichi Nishimura
Executive Officer & Head of Internal Control Officeno datano datano data
Jun-Ichi Oka
GM of Production Division & Director11.7yrsno data0.035%
¥ 7.4m
Masanori Ito
Manager of R&D Center & Director13.8yrsno data0.012%
¥ 2.5m
Hideki Otani
GM of Sales Division & Director7.6yrsno datano data
Mikihiro Toda
GM of Corporate Planning Division and Director3.7yrsno data0.11%
¥ 22.2m
Satoshi Tanaka
Executive Officer & GM of Reliability Assurance Division2.1yrsno datano data
Michikazu Saito
Executive Officer of Osaka Branch Sales Division2.1yrsno datano data
Hirohumi Yamamoto
Executive Officer & GM of Okayama Factory Production Division2.1yrsno datano data
Kiyoshi Tajima
Executive Officer of Tokyo First Branch Sales Division2.1yrsno datano data

3.7yrs

Average Tenure

75yo

Average Age

Experienced Management: 4538's management team is considered experienced (3.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mikio Toda
President & Representative Director47.7yrsno data2.12%
¥ 441.2m
Jun-Ichi Oka
GM of Production Division & Director15.7yrsno data0.035%
¥ 7.4m
Masanori Ito
Manager of R&D Center & Director11.7yrsno data0.012%
¥ 2.5m
Hideki Otani
GM of Sales Division & Director7.6yrsno datano data
Mikihiro Toda
GM of Corporate Planning Division and Director3.7yrsno data0.11%
¥ 22.2m
Minoru Sudo
Independent Outside Director9.7yrsno data0.012%
¥ 2.5m
Etsuo Aomoto
External Auditor12.7yrsno datano data
Takaaki Narasaki
Outside Corporate Auditor1.7yrsno datano data
Junji Kuwata
Standing Corporate Auditor4.7yrsno data0.012%
¥ 2.5m
Takashi Kashiwagi
Independent Outside Director3.7yrsno datano data
Yasuhiko Watanabe
Independent Outside Director1.7yrsno datano data

7.6yrs

Average Tenure

72yo

Average Age

Experienced Board: 4538's board of directors are considered experienced (7.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 09:21
End of Day Share Price 2025/02/07 00:00
Earnings2013/03/31
Annual Earnings2013/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Fuso Pharmaceutical Industries,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jayaprabha DhavaleVirtua Research Inc.